The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2017

Filed:

Jun. 04, 2014
Applicant:

Macrogenics, Inc., Rockville, MD (US);

Inventors:

Nadine Tuaillon, Gettysburg, PA (US);

Christopher Rankin, Cabin John, MD (US);

Assignee:

MacroGenics, Inc., Rockville, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/40 (2006.01); A61K 39/42 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); G01N 33/543 (2006.01); G01N 33/564 (2006.01); G01N 33/574 (2006.01); A61K 45/06 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/283 (2013.01); C07K 16/2887 (2013.01); G01N 33/54393 (2013.01); G01N 33/564 (2013.01); G01N 33/574 (2013.01); G01N 33/57426 (2013.01); A61K 2039/507 (2013.01); C07K 2317/24 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/72 (2013.01);
Abstract

The present invention relates to methods of treatment, prevention, management or amelioration of one or more symptoms of diseases or disorders associated with CD20 expression that encompass administration of a combination of: (A) one or more antibodies that specifically bind FcγRIIB, particularly human FcγRIIB, with greater affinity than said antibodies bind FcγRIIA, and (B) one or more antibodies that specifically bind to CD20. Such methods include methods of treating, preventing, managing or ameliorating one or more symptoms of a B cell related disease or disorder or an inflammatory disorder. The invention also provides pharmaceutical compositions comprising an anti-FcγRIIB antibody and an anti-CD20 antibody.


Find Patent Forward Citations

Loading…